Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine-Deprived Diet + Chemoradiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
NCT07755124Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2026
- Primary completion
- Aug 2028
01
Overview
Phase 2, randomised trial in rectal cancer (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Complete Response Rate at 6 months. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07755124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755124.